Risk and Effectiveness of Using Thrombin in Microvascular Free Tissue Transfer

  • Ki, Sae Hwi (Department of Plastic Surgery, Inha University of School of Medicine) ;
  • Kim, Han Joon (Department of Plastic Surgery, Inha University Hospital)
  • 투고 : 2014.04.11
  • 심사 : 2014.05.12
  • 발행 : 2014.05.30

초록

Purpose: Recent studies have reported on application of fibrin glue composed of fibrinogen and thrombin to nerve anastomosis, which can be another candidate for vessel anastomosis. However, no research regarding the risk and effectiveness of thrombin in microvascular free tissue transfer has been reported. Therefore, the aim of study is to determine the risk and effectiveness of thrombin on microvascular free tissue transfer through clinical cases. Materials and Methods: Twenty-five patients underwent free flap reconstruction for soft tissue defect or bone exposure in our institute from March 2011 to February 2014. In the group using thrombin, dissolved powder thrombin (5,000 IU/amp) was mixed with 10 mL normal saline. Saline mixed with thrombin was applied on the flap, recipient, and around vessel anastomosis. In the control group, free flap was performed using the same method, except using thrombin. We analyzed the results between the two groups. Results: All flaps survived. The group using thrombin included 14 patients and the control group included 11 patients. Hematoma was found in two cases, respectively, in each group. The group using thrombin showed lower incidence of hematoma than the control group. No difference in survival rate of the flap was observed between the thrombin group and the control group. Conclusion: Results of this study showed that use of saline mixed with thrombin in free tissue transfer may be safe and effective for prevention of hematoma formation in the recipient site.

키워드

참고문헌

  1. Glass GE, Nanchahal J. Why haematomas cause flap failure: an evidence-based paradigm. J Plast Reconstr Aesthet Surg 2012;65:903-10. https://doi.org/10.1016/j.bjps.2011.12.014
  2. Stephan B, Schenk JF, Nemeh A, Pindur G. The use of antithrombotic agents in microvascular surgery. Clin Hemorheol Microcirc 2009;43:51-6.
  3. Seegers WH, Warner ED, Brinkhous KM, Smith HP. The use of perified thrombin as an hemostatic agent. Science 1939;89:86-9.
  4. Schenk WG 3rd, Burks SG, Gagne PJ, Kagan SA, Lawson JH, Spotnitz WD. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg 2003;237:871-6.
  5. Cho AB, Junior RM. Effect of fibrin adhesive application in microvascular anastomosis: a comparative experimental study. Plast Reconstr Surg 2007;119:95-103. https://doi.org/10.1097/01.prs.0000245007.33054.98
  6. Egemen O, Ugurlu K, Ozkaya O, Sacak B, Sakiz D, Bas L. Anastomosis with fish-mouth technique using fibrin glue. J Craniofac Surg 2011;22:1047-51. https://doi.org/10.1097/SCS.0b013e3182135f39
  7. Cho AB, Junior RM. Application of fibrin glue in microvascular anastomoses: comparative analysis with the conventional suture technique using a free flap model. Microsurgery 2008;28:367-74. https://doi.org/10.1002/micr.20494
  8. Cho AB, Wei TH, Torres LR, Junior RM, Rugiero GM, Aita MA. Fibrin glue application in microvascular anastomosis: comparative study of two free flaps series. Microsurgery 2009;29:24-8. https://doi.org/10.1002/micr.20554
  9. Kheirabadi BS, Sieber J, Holcomb JB. Assessment of the thrombogenic effect of fibrin sealant dressing in a vascular surgery model in rabbits. J Invest Surg 2006;19:387-96. https://doi.org/10.1080/08941930600985744
  10. Fukuiwa T, Nishimoto K, Hayashi T, Kurono Y. Venous thrombosis after microvascular free-tissue transfer in head and neck cancer reconstruction. Auris Nasus Larynx 2008;35:390-6. https://doi.org/10.1016/j.anl.2007.10.005
  11. McLean DH, Buncke HJ Jr. Autotransplant of omentum to a large scalp defect, with microsurgical revascularization. Plast Reconstr Surg 1972;49:268-74. https://doi.org/10.1097/00006534-197203000-00005
  12. Vibe P, Pless J. A new method of skin graft adhesion. Scand J Plast Reconstr Surg 1983;17:263-4. https://doi.org/10.3109/02844318309013129
  13. Pearl RM, Wustrack KO, Harbury C, Rubenstein E, Kaplan EN. Microvascular anastomosis using a blood product sealantadhesive. Surg Gynecol Obstet 1977;144:227-31.
  14. Isogai N, Fukunishi K, Kamiishi H. Use of fibrin glue to minimize bleeding of microvascular repairs in hypertensive rats. Microsurgery 1992;13:321-4. https://doi.org/10.1002/micr.1920130606
  15. Han SK, Kim SW, Kim WK. Microvascular anastomosis with minimal suture and fibrin glue: experimental and clinical study. Microsurgery 1998;18:306-11. https://doi.org/10.1002/(SICI)1098-2752(1998)18:5<306::AID-MICR2>3.0.CO;2-8
  16. Sagi A, Yu HL, Ferder M, Gordon MJ, Strauch B. "No suture" microanastomosis using Vicryl rings and fibrin adhesive system: an unsuccessful attempt. Plast Reconstr Surg 1987;79:776-7. https://doi.org/10.1097/00006534-198705000-00017
  17. Moskovitz MJ, Bass L, Zhang L, Siebert JW. Microvascular anastomoses utilizing new intravascular stents. Ann Plast Surg 1994;32:612-8. https://doi.org/10.1097/00000637-199406000-00009
  18. Drake DB, Faulkner BC, Amiss LR Jr, Spotnitz WD, Morgan RF. Thrombogenic effects of a nonthrombin-based fibrin sealant compared with thrombin-based fibrin sealant on microvenous anastomoses in a rat model. Ann Plast Surg 2000;45:520-4. https://doi.org/10.1097/00000637-200045050-00009
  19. Frost-Arner L, Spotnitz WD, Rodeheaver GT, Drake DB. Comparison of the thrombogenicity of internationally available fibrin sealants in an established microsurgical model. Plast Reconstr Surg 2001;108:1655-60. https://doi.org/10.1097/00006534-200111000-00033
  20. Puri RN. Phospholipase A2: its role in ADP- and thrombininduced platelet activation mechanisms. Int J Biochem Cell Biol 1998;30:1107-22. https://doi.org/10.1016/S1357-2725(98)00080-6
  21. Padubidri AN, Browne E. A new method of applying fibrin glue at the microvascular anastomotic site: the "paintbrush" technique. Microsurgery 1996;17:428-30. https://doi.org/10.1002/(SICI)1098-2752(1996)17:8<428::AID-MICR2>3.0.CO;2-A